I think I only have about a minute left, so I'll play Alex Trebek here.
As you were all talking, I was taking some notes about drivers of the system that if we get right, if we design a Canadian system, could be cost-savers. I have: cost-related non-adherence; a national formulary, with some bulk buying; perhaps exclusive market access for certain drugs; single administration or centralized administration instead of maybe thousands of private plans; better prescription practices; and better evidence-based evaluation and efficacy assessment.
Does anything there jar anybody? Are those basically the factors? Am I missing something big, or is anything wrong there?